Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
began, COPD, ESMO, excise, IRA, Korean, linvoseltamab, neoadjuvant, Notably, outlined, outset, pattern, PHOTON, PULSAR, randomized, recoverability, recoverable, reliably, undiscounted, Virginia, vision, West
Removed:
aimed, alleviate, allocate, American, attempt, Biden, Biomedical, collected, constrained, Division, English, essential, evidenced, exist, formal, immunity, intervener, intervention, justifying, legislative, long, lowering, model, mutually, Pfizer, prematurity, proposal, referencing, regular, retinopathy, Rinat, secondary, sooner, speculation, suffering, upheld, uptake, urgency, wholly
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view